We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetro Bank Regulatory News (MTRO)

Share Price Information for Metro Bank (MTRO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.95
Bid: 31.00
Ask: 31.90
Change: 0.70 (2.24%)
Spread: 0.90 (2.903%)
Open: 32.55
High: 32.55
Low: 31.10
Prev. Close: 31.25
MTRO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Metro Bank Plc

18 Nov 2021 07:00

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Willett Advisors LLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

1. Willett Advisors LLC (NY, USA)

2. 060112 Investment Holdings LLC (Wilmington, Delaware USA)

3. Willett Select Investors (Tax Exempt) I LP (Wilmington, Delaware, USA)

4. Dogfish Head Investments LLC (Wilmington, Delaware, USA)

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Metro Bank Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

17 November 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

0.0001p ordinary

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2644742

2.72

 

 

(2) Cash-settled derivatives:

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

2644742

2.72

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

17 November 2021

Contact name:

Richa Gulati

Telephone number*:

212-783-9500

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211117006327/en/

Copyright Business Wire 2021

Date   Source Headline
14th Mar 20195:24 pmRNSHolding(s) in Company
13th Mar 20195:45 pmRNSHolding(s) in Company
13th Mar 20195:33 pmRNSHolding(s) in Company
11th Mar 20196:19 pmRNSBlock listing Interim Review
11th Mar 20196:06 pmRNSHolding(s) in Company
11th Mar 20195:58 pmRNSHolding(s) in Company
4th Mar 20193:59 pmRNSDirector/PDMR Shareholding
4th Mar 20193:27 pmRNSHolding(s) in Company
4th Mar 20191:18 pmRNSDirector/PDMR Shareholding
1st Mar 20195:17 pmRNSDirector/PDMR Shareholding
1st Mar 20193:51 pmRNSTotal Voting Rights
28th Feb 20194:41 pmRNSSecond Price Monitoring Extn
28th Feb 20194:35 pmRNSPrice Monitoring Extension
26th Feb 20195:19 pmRNSPrelim full year results & Q4 trading update 2018
26th Feb 20194:40 pmRNSSecond Price Monitoring Extn
26th Feb 20194:35 pmRNSPrice Monitoring Extension
26th Feb 20194:24 pmRNSMetro Bank standby underwrite & prelim results
22nd Feb 20197:00 amRNSMetro awarded £120 million in funding from BCR Ltd
21st Feb 201910:11 amRNSHolding(s) in Company
20th Feb 20194:44 pmRNSHolding(s) in Company
18th Feb 20195:24 pmRNSHolding(s) in Company
12th Feb 20195:28 pmRNSHolding(s) in Company
8th Feb 20194:32 pmRNSHolding(s) in Company
4th Feb 20195:00 pmRNSHolding(s) in Company
4th Feb 201910:06 amRNSTotal Voting Rights
4th Feb 20199:58 amRNSHolding(s) in Company
4th Feb 20199:44 amRNSHolding(s) in Company
31st Jan 20195:24 pmRNSHolding(s) in Company
23rd Jan 20197:00 amRNSMETRO BANK FY18 RESULTS PREVIEW & TRADING UPDATE
2nd Jan 20193:14 pmRNSTotal Voting Rights
19th Dec 201810:30 amRNSNon-Executive Director Appointment
3rd Dec 20183:44 pmRNSTotal Voting Rights
16th Nov 201812:51 pmRNSHolding(s) in Company
13th Nov 201811:08 amRNSDirector/PDMR Shareholding
9th Nov 20183:09 pmRNSDirector/PDMR Shareholding
7th Nov 20185:15 pmRNSHolding(s) in Company
6th Nov 20184:31 pmRNSDirector/PDMR Shareholding
1st Nov 20184:06 pmRNSTotal Voting Rights
1st Nov 20182:04 pmRNSHolding(s) in Company
31st Oct 201812:04 pmRNSDirector/PDMR Shareholding
30th Oct 201810:57 amRNSHolding(s) in Company
24th Oct 20187:00 amRNS3rd Quarter Results
1st Oct 20183:01 pmRNSTotal Voting Rights
21st Sep 20182:08 pmRNSDirector/PDMR Shareholding
20th Sep 20184:28 pmRNSDirector/PDMR Shareholding
20th Sep 201812:59 pmRNSBlock listing Interim Review
19th Sep 20184:15 pmRNSDirector/PDMR Shareholding
19th Sep 201810:19 amRNSNon-Executive Director Appointment
18th Sep 20189:34 amRNSDirector/PDMR Shareholding
14th Sep 20185:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.